IPP Bureau
Indian medical devices industry to grow at 28% annually to reach US$ 50 bn by 2030: Health Minister
By IPP Bureau - October 01, 2022
Department and Industry Associations to organize 3 days National Level Expo on Indian Medical Devices Sector at Pragati Maidan, New Delhi between 9-11 Dec 2022, first of its kind expo in India
Dr VK Paul delivers lecture at NITI Aayog’s First India Development Strategies Lecture Series
By IPP Bureau - October 01, 2022
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
Philips shareholders appoint Roy Jakobs as next President and CEO
By IPP Bureau - October 01, 2022
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
Japan homegrown COVID-19 mRNA vaccine needs superior safety and efficacy data for success, says GlobalData
By IPP Bureau - October 01, 2022
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Zydus receives final approval from the USFDA for Sildenafil for Oral Suspension
By IPP Bureau - October 01, 2022
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
USFDA inspects Zydus Lifesciences Ahmedabad SEZ facility
By IPP Bureau - September 30, 2022
The company will address the observations within a stipulated timeline working with the regulators
Lupin receives US FDA approval for Mirabegron Extended-Release tablets
By IPP Bureau - September 30, 2022
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
Lupin receives warning letter from US FDA
By IPP Bureau - September 30, 2022
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
CAPED Trust and AstraZeneca India launch ‘Ganga Godavari Cancer Screening Program’ in Mathura
By IPP Bureau - September 30, 2022
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
Emmes acquires Clinical Edge
By IPP Bureau - September 30, 2022
The combination of Optym, Emmes' ophthalmology certification unit, and Clinical Edge will make the organization a leader in ophthalmic certification and training services
Lupin launches Sildenafil for Oral Suspension in US
By IPP Bureau - September 30, 2022
Sildenafil for Oral Suspension (RLD Revatio) had estimated annual sales of US $64 million in the US
Torrent Pharma to acquire Curatio Healthcare for Rs. 2,000 Cr
By IPP Bureau - September 28, 2022
The consideration includes Rs. 115 crore (on the date of signing) of cash and cash equivalents in the acquired business indicating an Enterprise Value of Rs. 1,885 crore
South Korea nextgen sequencing tests market to grow at 4% CAGR during 2022-2030: GlobalData
By IPP Bureau - September 28, 2022
There is also a growing interest in whole generation sequencing (WGS)
Cardiac Surgeons call for lifestyle and dietary changes on World Heart Day
By IPP Bureau - September 28, 2022
There are certain foods can influence blood pressure, triglycerides, cholesterol levels and inflammation, all of which are risk factors for heart disease.
NIHR addresses research in surgery in India
By IPP Bureau - September 28, 2022
The two-day meeting in the city was organized in collaboration with the University of Birmingham, Christian Medical College Ludhiana, and Birmingham Clinical Trials Unit
